1. Home
  2. INAB vs CLRO Comparison

INAB vs CLRO Comparison

Compare INAB & CLRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IN8bio Inc.

INAB

IN8bio Inc.

HOLD

Current Price

$1.20

Market Cap

13.7M

Sector

Health Care

ML Signal

HOLD

Logo ClearOne Inc. (DE)

CLRO

ClearOne Inc. (DE)

HOLD

Current Price

$5.34

Market Cap

14.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
INAB
CLRO
Founded
2016
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
13.7M
14.4M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
INAB
CLRO
Price
$1.20
$5.34
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
48.6K
8.2M
Earning Date
05-11-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$46,067,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.59
52 Week Low
$1.17
$2.71
52 Week High
$2.73
$16.50

Technical Indicators

Market Signals
Indicator
INAB
CLRO
Relative Strength Index (RSI) 33.80 46.01
Support Level $1.17 $4.01
Resistance Level $1.50 $5.62
Average True Range (ATR) 0.07 2.51
MACD -0.02 -0.38
Stochastic Oscillator 5.51 0.79

Price Performance

Historical Comparison
INAB
CLRO

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.

About CLRO ClearOne Inc. (DE)

ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.

Share on Social Networks: